Lawrence B. Cohen’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-615
Closed -$225K 73
2022
Q4
$225K Buy
+615
New +$218K 0.12% 87
2022
Q1
Sell
-746
Closed -$206K 80
2021
Q4
$206K Buy
+746
New +$189K 0.08% 96
2016
Q4
Sell
-3,400
Closed -$273K 77
2016
Q3
$273K Hold
3,400
0.16% 66
2016
Q2
$268K Buy
3,400
+50
+1% +$3.76K 0.16% 80
2016
Q1
$241K Hold
3,350
0.16% 65
2015
Q4
$282K Hold
3,350
0.19% 61
2015
Q3
$280K Hold
3,350
0.19% 60
2015
Q2
$280K Hold
3,350
0.18% 61
2015
Q1
$243K Hold
3,350
0.15% 65
2014
Q4
$231K Hold
3,350
0.14% 67
2014
Q3
$217K Sell
3,350
-100
-3% -$6.33K 0.14% 69
2014
Q2
$214K Sell
3,450
-150
-4% -$8.95K 0.14% 68
2014
Q1
$212K Buy
+3,600
New +$201K 0.15% 67

Other funds holding LLY

Lawrence B. Cohen's LLY Position: Q1 2023 in Review

Lawrence B. Cohen sold out of Eli Lilly (LLY) in Q1 2023, closing a stake of 615 shares — an estimated $225K sold.

Lawrence B. Cohen first reported a position in LLY in Q1 2014 and held it in 13 quarters. The position peaked at $282K in Q4 2015. 2,615 funds tracked by Wall St. Rank hold LLY as of Q1 2023.

  • Lawrence B. Cohen reported no remaining Eli Lilly position as of Q1 2023 after selling out during the quarter.
  • Lawrence B. Cohen sold 615 Eli Lilly shares in Q1 2023, an estimated $225K.
  • Lawrence B. Cohen first reported a position in Eli Lilly in Q1 2014 and held it in 13 quarters.
  • Lawrence B. Cohen's Eli Lilly position peaked at $282K in Q4 2015.
  • 2,615 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2023.

Based on Lawrence B. Cohen's 13F filing for Q1 2023, filed 11 May 2023.